PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Desipramine and Darunavir Interaction

Drug interaction information between Desipramine and Darunavir.

Desipramine and Darunavir have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Desipramine and Darunavir. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.

Drug A

Desipramine

Tricyclic Antidepressant (TCA)

Drug B

Darunavir

HIV Protease Inhibitor

How They Interact

Darunavir slows down the process your body uses to get rid of desipramine, leading to higher levels of the drug in your blood.

What To Do

Your doctor should use a lower dose of desipramine and watch for side effects like dizziness or fainting.

FDA Label Information

Tricyclic Antidepressants (TCAs): amitriptyline, desipramine, imipramine, nortriptyline ↑ amitriptyline ↑ desipramine ↑ imipramine ↑ nortriptyline Use a lower dose of the tricyclic antidepressants and trazodone due to potential increased adverse events such as nausea, dizziness, hypotension and syncope.

Frequently Asked Questions

Can I take Desipramine and Darunavir together?

This is a minor interaction. Your doctor should use a lower dose of desipramine and watch for side effects like dizziness or fainting.

How serious is the interaction between Desipramine and Darunavir?

This interaction is classified as "minor" severity by the FDA. Minor interactions are unlikely to cause significant problems but should still be mentioned to your healthcare provider.

Why do Desipramine and Darunavir interact?

Darunavir slows down the process your body uses to get rid of desipramine, leading to higher levels of the drug in your blood.

Understanding the Desipramine and Darunavir Interaction

FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Desipramine belongs to the Tricyclic Antidepressant (TCA) class and Darunavir belongs to the HIV Protease Inhibitor class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Darunavir slows down the process your body uses to get rid of desipramine, leading to higher levels of the drug in your blood. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Desipramine has 18 total documented interactions on file in this dataset, and Darunavir has 101. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor should use a lower dose of desipramine and watch for side effects like dizziness or fainting. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Desipramine or Darunavir based on a web page, speak with your prescriber or pharmacist before making any change.

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.